StockData
Savara Inc logo

Savara Inc (SVRA) stock

SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$4.48+0.02 (+0.34%)

Close on Nov 17, 2026Market cap $920.46MP/E –Yield –

Savara cash

Cash and short-term investments held at the end of each period.

Savara's cash was $173.03M at Jun 30, 2026. For fiscal 2025 it was $235.70M, up 20.1% from the year before. Over ten years it grew 19.1% a year on average. The highest annual figure on record is $235.70M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$235.70M+20.1%
FY2024Dec 31, 2024$196.33M+21.0%
FY2023Dec 31, 2023$162.32M+29.0%
FY2022Dec 31, 2022$125.88M-21.9%
FY2021Dec 31, 2021$161.17M+96.1%
FY2020Dec 31, 2020$82.19M-32.5%
FY2019Dec 31, 2019$121.76M+9.9%
FY2018Dec 31, 2018$110.83M+17.5%
FY2017Dec 31, 2017$94.31M+734.6%
FY2016Dec 31, 2016$11.30M-72.4%
FY2015Dec 31, 2015$41.00M+223.1%
FY2014Dec 31, 2014$12.69M-50.6%
FY2013Dec 31, 2013$25.68M-29.7%
FY2012Dec 31, 2012$36.51M-28.0%
FY2011Dec 31, 2011$50.70M+81.2%
FY2010Dec 31, 2010$27.98M+222.8%
FY2009Dec 31, 2009$8.67M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$173.03M+18.2%
Q1 FY2026Mar 31, 2026$202.77M+17.5%
Q4 FY2025Dec 31, 2025$235.70M+20.1%
Q3 FY2025Sep 30, 2025$124.39M-43.3%
Q2 FY2025Jun 30, 2025$146.44M+20.5%
Q1 FY2025Mar 31, 2025$172.50M+20.6%
Q4 FY2024Dec 31, 2024$196.33M+21.0%
Q3 FY2024Sep 30, 2024$219.44M+30.4%
Q2 FY2024Jun 30, 2024$121.52M+15.5%
Q1 FY2024Mar 31, 2024$143.04M+24.6%
Q4 FY2023Dec 31, 2023$162.32M+29.0%
Q3 FY2023Sep 30, 2023$168.25M+25.5%
Q2 FY2023Jun 30, 2023$105.18M-26.2%
Q1 FY2023Mar 31, 2023$114.78M-24.4%
Q4 FY2022Dec 31, 2022$125.88M-21.9%
Q3 FY2022Sep 30, 2022$134.08M-21.5%
Q2 FY2022Jun 30, 2022$142.44M-21.2%
Q1 FY2022Mar 31, 2022$151.80M-21.2%
Q4 FY2021Dec 31, 2021$161.17M+96.1%
Q3 FY2021Sep 30, 2021$170.81M+81.1%
Q2 FY2021Jun 30, 2021$180.67M+81.4%
Q1 FY2021Mar 31, 2021$192.71M+83.6%
Q4 FY2020Dec 31, 2020$82.19M-32.5%
Q3 FY2020Sep 30, 2020$94.34M-11.2%
Q2 FY2020Jun 30, 2020$99.61M-10.9%
Q1 FY2020Mar 31, 2020$104.99M-0.2%
Q4 FY2019Dec 31, 2019$121.76M+9.9%
Q3 FY2019Sep 30, 2019$106.28M-5.1%
Q2 FY2019Jun 30, 2019$111.73M+49.5%
Q1 FY2019Mar 31, 2019$105.18M+23.8%
Q4 FY2018Dec 31, 2018$110.83M+17.5%
Q3 FY2018Sep 30, 2018$112.05M+110.3%
Q2 FY2018Jun 30, 2018$74.76M+22.3%
Q1 FY2018Mar 31, 2018$84.98M+989.5%
Q4 FY2017Dec 31, 2017$94.31M+734.6%
Q3 FY2017Sep 30, 2017$53.29M+97.4%
Q2 FY2017Jun 30, 2017$61.13M–
Q1 FY2017Mar 31, 2017$7.80M–
Q4 FY2016Dec 31, 2016$11.30M–
Q3 FY2016Sep 30, 2016$27.00M–

More Savara figures

See a number that looks wrong?